elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q24242032-50D5C754-5E29-41CF-9C11-309B26BF6C65
Q24242032-50D5C754-5E29-41CF-9C11-309B26BF6C65
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24242032-50D5C754-5E29-41CF-9C11-309B26BF6C65
Fluid and diuretic therapy for preventing cisplatin-induced nephrotoxicity
P2860
Q24242032-50D5C754-5E29-41CF-9C11-309B26BF6C65
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24242032-50D5C754-5E29-41CF-9C11-309B26BF6C65
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
100251e62c3d968841f1e1c4761441d824992762
P2860
Phase II study of cisplatin plus epirubicin salvage chemotherapy in refractory germ cell tumors.